The Emergency Medicine Program at CHÉOS conducts research in resuscitation, clinical prediction rules, cardiovascular emergencies, patient safety, infectious diseases, mental health care, and addictions/substance use, with care and research goals that are aligned with the needs of local patients and that aim to support patients and physicians across B.C.
The Emergency Medicine Program at CHÉOS conducts research in resuscitation, clinical prediction rules, cardiovascular emergencies, patient safety, infectious diseases, mental health, addictions and substance use, with care and research goals that are aligned with the needs of local patients and that aim to support patients and physicians across British Columbia.
The St. Paul’s Emergency Research Group was founded by Dr. Jim Christenson in 1994, and under his leadership became one of the pre-eminent emergency research groups in Canada, with an annual output of over 35 peer-reviewed publications. Now a CHÉOS research program, this group of investigators works in close collaboration to develop study protocols, analyze data, and disseminate results through publication and other platforms.
The emergency department at St Paul’s Hospital has 90 000 annual visits and is a provincial cardiac referral center. It serves many patients with complex health and social needs. All researchers in the program are CHÉOS Scientists and are involved with the British Columbia Emergency Medicine Network, multi-platform knowledge exchange and translation network that provides 1,400 B.C. emergency practitioners with evidence-based information to improve patient care.
Dr. Frank Scheuermeyer completed medical school at the University of Alberta, residency training at the University of British Columbia, and is an emergency physician at St. Paul’s Hospital and Mount St. Joseph’s Hospital.
The primary research & methodology areas the Emergency Medicine Program undertakes are:
In 2005, BC resuscitation researchers partnered with BC Emergency Health Services (BCEHS) to lead one of ten North American research centers under the Resuscitation Outcomes Consortium (ROC) that focused on out-of- hospital cardiac arrest and trauma. Through this collaboration, the BC Resuscitation Research Unit was created and led by Dr. Jim Christenson to identify and study consecutive out-of-hospital cardiac arrest cases in urban BC. Over the next decade, affiliated researchers performed numerous interventional clinical trials, observational analyses, and quality improvement initiatives. The BC Cardiac Arrest Registry was created in 2015 to capture data for out-of-hospital cardiac arrests responded to by BCEHS and Fire Department first responders in BC’s metropolitan regions. In 2016, the unit joined 3 other provinces to create the Canadian Resuscitation Outcomes Consortium (CanROC) national cardiac arrest registry. CanROC has grown to include most provinces as a national registry of sudden unexpected death, in partnership with the Heart and Stroke Foundation of Canada. It supports quality improvement and research, and BC continues to play a lead role. As a result of this active focus on the quality and outcomes of resuscitation, the likelihood of survival in BC from an out-of-hospital cardiac arrest significantly increased. In 2020, the unit spearheaded “CanSAVE”, a national research collaborative to transform the response to cardiac arrest beyond traditional emergency response models and improve survival through world class resuscitation research.
In 2021, the resuscitation research unit formally became the BC Resuscitation Research Collaborative (RESURECT). Under the shared leadership of Dr. Jim Christenson and Dr. Brian Grunau, BC RESURECT continues to work on strengthening BC’s contributions to resuscitation science.
Two of the most common cardiovascular emergencies are chest pain and arrhythmias (Irregular heart rhythms). Chest pain accounts for nearly one million ED visits annually in Canada, and quickly distinguishing serious heart problems, such as heart attacks, from the many patients who have non-serious diagnoses, without administering unnecessary tests or using excessive resources, can be very challenging. Research by Dr. Christenson and Dr. Frank Scheuermeyer has demonstrated that many patients who would previously have prolonged ED lengths-of-stay, or been admitted to hospital, or had extensive testing, can be quickly and safely discharged home, or have testing deferred to outpatient settings.
Atrial fibrillation and flutter are two common arrhythmias. Many patients have prolonged ED stays, or are admitted to hospital, or, in some cases, undergo treatments that worsen the illness. Dr. Scheuermeyer’s research has allowed emergency physicians to quickly identify high-risk patients while permitting the safe, rapid discharge of lower-risk patients. For both conditions, research goals are to improve the identification of high-risk patients, while decreasing patient anxiety and ED resource use.
Other areas of research in cardiovascular emergencies undertaken by the Program include:
Stroke is a devastating illness and many patients struggle to regain their pre-stroke lives. Early recognition and treatment are some of the most important aspects of care. Dr. Christenson is the lead investigator in a multi-provincial randomized trial, funded by Brain Canada, investigating a new neuroprotective drug (Nerinetide) to reduce damage caused by stroke. The intervention is given by paramedics prior to hospital arrival, and patients are followed for neurologic outcomes over 90 days.
St. Paul’s Hospital serves a large number of patients with infections, sepsis, and septic shock. Dr. Rob Stenstrom has been leading the infections and sepsis research program at St. Paul’s for over 10 years. St. Paul’s has been an innovator in sepsis diagnosis and treatment in the ED and was awarded the Canadian College of Health Care3M Canadian Health Team Award for the development and implementation of the Providence Health Care Emergency Department Sepsis Protocol. Dr. Stenstrom has been involved with the development of the Canadian Association of Emergency Physicians (CAEP) guidelines for ED sepsis management with three iterations over the past decade and recently published a multi-center trial optimizing the utility of blood cultures.
Current studies include:
Every ED serves patients with acute and chronic mental health concerns; at SPH many patients also struggle with social determinants of health including access to housing, food, and water. Dr. David Barbic leads research in mental health.
Current projects include:
Dr. Andrew Kestler enhances care and improves outcomes for patients with opioid use disorder. Building on SPH’s expertise in harm reduction, the CHÉOS Emergency Medicine Program, in collaboration with addictions specialists, the City of Vancouver, and provincial public health officials, implements and studies novel approaches to deliver care to vulnerable populations. The aim of the Program is not only to improve patient care but also to contribute evidence that will help patients beyond SPH. He is currently focused on:
Alcohol use disorder is a severe public health problem and many patients attend EDs with alcohol-related complaints. Dr. Scheuermeyer is investigating optimal ED care, as well as the scope of this issue.
Patient safety is a complex and multifaceted problem, and patient harm remains a pervasive global healthcare issue. The ED can be a crowded and often high-hazard unit. A mismatch between demand and capacity contributes to adverse patient outcomes, including unnecessary hospital admission, injury, or death. Dr. Garth Hunte advances work to implement a proactive and productive safety strategy in urban emergency care.
Current work includes:
Previous work included an ethnographic analysis of how emergency care providers create safety for patients in everyday practice, implementation of a framework based on resilience engineering principles in the context of emergency care, and retrospective evaluation of the effect of structured clinical assessment to risk-stratify patients with a higher likelihood of admission.
Want to learn more about our Emergency Medicine Program? Read related stories below.
New research from the CHÉOS Emergency Medicine Program shows that paramedic encounters decreased by 15 per cent in the first three months of the pandemic
Read More
CHÉOS Scientist Dr. Brian Grunau is PI of this study, which will also determine how many paramedics have had COVID-19 and will investigate how long antibodies last
Read More
